NICOLE FUNT: Open Payments
NPI 1073575205 · PITTSBURGH, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$315 in 14 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $282 · 2025 $315
Food & beverage: $315
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 3 | $54 |
| Novartis Pharmaceuticals Corporation | 2 | $53 |
| UCB, Inc. | 2 | $43 |
| Regeneron Healthcare Solutions, Inc. | 1 | $38 |
| REVANCE THERAPEUTICS, INC. | 1 | $30 |
| MAYNE PHARMA COMMERCIAL LLC | 1 | $29 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $23 |
| Galderma Laboratories, L.P. | 1 | $22 |
| Biofrontera Inc. | 1 | $17 |
| Organon LLC | 1 | $5 |
Products named: OTEZLA, COSENTYX, Bimzelx, DUPIXENT, DAXXIFY, Winlevi, AKLIEF.
Industry payments across PA — which companies pay providers there.
